Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001902368-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-07 | 2026-01-05+ | TVTX | Inrig Jula | Chief MEDICAL Off | S - Sale | $39.74 | -2,476 | 86.8K | -3% | -$98.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 445 | $37.75 | 86,311 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-05 | S | D | 2,031 | $40.18 | 86,756 | D | — | — |